Reed Joshua 4
4 · Omega Therapeutics, Inc. · Filed Jun 2, 2022
Insider Transaction Report
Form 4
Reed Joshua
Chief Financial Officer
Transactions
- Award
Option (Right to Buy)
2022-05-31+320,000→ 320,000 totalExercise: $2.27Exp: 2032-05-30→ Common Stock (320,000 underlying)
Footnotes (1)
- [F1]The options vest and become exercisable with respect to 25% of the underlying shares on May 23, 2023 and in equal quarterly installments thereafter such that the option will become fully vested and exercisable on May 23, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date.